Fingerprint
Dive into the research topics of 'A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically